Founder Directory
Built by Keitoto
Founders6
Known for these resultsRole83%Role is parsed from founder titles in yc.db. Known for 83% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company33%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 33% of these rows have at least one match.School67%School is matched from bios, case-sensitive for acronyms. 67% of these rows have at least one match.
- Alfredo GonzalezFounder/CEO · OmantaS26Healthcare · San Francisco
- Ranad Humeidi@RanadhumeidiFounder and Chief Scientific Officer · OmantaS26Healthcare · San Francisco
- Omar Elamin@omarelamin_Founder/CTO · CarettaW26B2B · San Francisco
- Arianna Galbraith@ArigalbraithFounder/CEO · Oma CareW24Healthcare · New York
- James GalbraithFounder/CTO · Oma CareW24Healthcare · New York
- Omar MughalFounder · GoodCourseW23B2B · London
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Alfredo GonzalezOmantaFounder/CEOSummer 2026HealthcareSan Francisco, United States4—Ranad HumeidiOmantaFounder and Chief Scientific OfficerSummer 2026HealthcareSan Francisco, United States4https://x.com/RanadhumeidiOmar ElaminCarettaFounder/CTOWinter 2026B2BSan Francisco, United States4https://x.com/omarelamin_Arianna GalbraithOma CareFounder/CEOWinter 2024HealthcareNew York, United States2https://x.com/ArigalbraithJames GalbraithOma CareFounder/CTOWinter 2024HealthcareNew York, United States2—Omar MughalGoodCourseFounderWinter 2023B2BLondon, United Kingdom8—
Showing 1–6 of 6 founders
Ranad Humeidi
Founder and Chief Scientific Officer·Omanta
PRIMARY INFO
RoleFounder and Chief Scientific Officer
Team size4
BatchSummer 2026
LocationSan Francisco, United States
Company statusActive
StageEarly
BIO
Co-founder & CSO at Omanta, working with patients to turn frontier science into personalized treatment strategies. Harvard Chemical Biology PhD in 3 years; identified a druggable ulcerative colitis mechanism that led to a multimillion-dollar GSK collaboration. Built and directed a multimillion-dollar rare cancer program for one patient, coordinating researchers, physicians, biotechs, and drug developers. Led strategies for 12+ complex patients after standard options were exhausted.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
CredentialsPhD
DisciplineResearcherKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
OmantaA research lab for one
IndustryHealthcare
Websiteomanta.com/
Team size4
X—
LocationSan Francisco, United States
BatchSummer 2026
Co-foundersAlfredo Gonzalez
